Informatics & Data Solutions

NeoGenomics' commitment to advancing cancer care with real-world multi-modal oncology data solutions makes us a valuable partner to pharmaceutical companies.

Understanding the vital role that data plays in precision oncology, NeoGenomics has the scientific expertise and innovation to help pharma companies succeed sooner.


  • Develop custom use case driven by our partner's goals and timelines for product development
  • Collate and distribute data in diverse ways to meet the needs of our partners
  • Support high impact pre-launch planning, including forecasting, prevalence studies, understanding diagnostic landscape and testing trends to help our partners recognize immediate success upon launch


  • Oncology and diagnostic expertise tailored to help pharma with product planning
  • Deep analytical insights working side by side to seek the answers to cancer's never ending questions
  • Data accuracy derived from an expansive portfolio of NeoGenomics run oncology tests spanning multiple methodologies
Planning for launch and commercialization

NeoEngage: Commercialization Support

Unparalleled Data Insights to Drive Biomarker Adoption and Precision Oncology Across Your Therapies

Real-time signals, deep analytics, and multi-modal insights to drive your brand’s efforts in advancing biomarker testing and awareness of targeted therapies in oncology. We partner with brand teams from emerging biotech across the spectrum to leading top 20 pharma to help amplify their diagnostic testing and precision medicine strategy.

Digital Image Library


Access Our Library for Image and AI Powered Insights

Over 2,100,0000 digital pathology images, including H&Es and IHCs, available for machine learning and AI model development and training. Our Images, paired with rich patient and clinical history, provides your team the metadata to help you build algorithms and study biomarkers and rare cohorts efficiently.

Clinical Trial Optimization and Awareness


Targeted Outreach to Providers with Nearby Patients to Match Your Patient Profile Trial Criteria

Identifying patients that match your trial’s inclusion/exclusion criteria from our pool of 1,900,000 patient profiles with over 500,000 patients tested annually. Our goal is to help educate, raise awareness and inform Oncologists of your clinical trial as a potential treatment option for their patients. Together, we can connect physicians with sponsors and nearby PI’s to help you succeed with your clinical trial awareness and recruitment efforts.

NeoEngage: Commercialization Support

The Difference Is In Our Data


We collect data from our comprehensive clinical test menu that provide a diverse population data set representative of the entire US population including race, ethnicity, rural and urban communities. We have over 1,900,00 patient profiles from over 40,000 unique providers across 4,000 healthcare organizations.


We tailor our data to your specific needs throughout the lifecycle planning process. Our multi-modal test menu captures a wide variety of various cancer diagnoses and progression throughout the patient journey.


One of the largest US oncology reference laboratories in the country, utilizing only Neo data. Our deep diagnostic and testing knowledge and expertise allows us to focus on data solutions that meet your needs.


We are a proven leader in real-world, multi-modal oncology data.



Learn more about the collaboration between NeoGenomics and ConcertAI. The first population-scale hematology data set investigating real-world clinical practice and outcomes in hematologic malignancies in the U.S.



Click here to view the Press Release

Click here to download the fact sheet and learn more

Powerful Joint Solutions to Help You Succeed Sooner

Linked Real-World Datasets that include EMR and Genomics Data:

CDx Launch Planning

Translational Discovery

External Control Arms


New Product Planning

Market Access

Check out our latest Precision Medicine Resources

Paroxysmal Nocturnal Hemoglobinuria:   
The Current Testing Landscape and Emerging Therapies


Examining RET Fusion:  
How Real-World Data (RWD) can be used to support a Tumor-Agnostic Era


AI-Enabled Digital Pathology
Using AI in precision oncology to enhance screening and streamline workflows.


The Emergence of Multi-modal Real-world data
The power of Clinico-Genomic data versus Traditional RWD Sources



Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients